These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15577602)
1. Clinical assessment in adult onset idiopathic inflammatory myopathy. Sultan SM Curr Opin Rheumatol; 2004 Nov; 16(6):668-72. PubMed ID: 15577602 [TBL] [Abstract][Full Text] [Related]
2. Defining Clinical Improvement in Adult and Juvenile Myositis. Rider LG; Giannini EH; Harris-Love M; Joe G; Isenberg D; Pilkington C; Lachenbruch PA; Miller FW; J Rheumatol; 2003 Mar; 30(3):603-17. PubMed ID: 12610824 [TBL] [Abstract][Full Text] [Related]
3. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. Rider LG Rheum Dis Clin North Am; 2002 Nov; 28(4):935-77. PubMed ID: 12506779 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic inflammatory myositis. Tieu J; Lundberg IE; Limaye V Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):149-68. PubMed ID: 27421222 [TBL] [Abstract][Full Text] [Related]
5. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Miller FW Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i82-5. PubMed ID: 22460145 [TBL] [Abstract][Full Text] [Related]
6. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Miller FW; Rider LG; Chung YL; Cooper R; Danko K; Farewell V; Lundberg I; Morrison C; Oakley L; Oakley I; Pilkington C; Vencovsky J; Vincent K; Scott DL; Isenberg DA; Rheumatology (Oxford); 2001 Nov; 40(11):1262-73. PubMed ID: 11709610 [TBL] [Abstract][Full Text] [Related]
7. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Isenberg DA; Allen E; Farewell V; Ehrenstein MR; Hanna MG; Lundberg IE; Oddis C; Pilkington C; Plotz P; Scott D; Vencovsky J; Cooper R; Rider L; Miller F; Rheumatology (Oxford); 2004 Jan; 43(1):49-54. PubMed ID: 12867580 [TBL] [Abstract][Full Text] [Related]
11. Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Rockette-Wagner B; Saygin D; Moghadam-Kia S; Oddis C; Landon-Cardinal O; Allenbach Y; Dzanko S; Koontz D; Neiman N; Aggarwal R Rheumatology (Oxford); 2021 Dec; 60(12):5713-5723. PubMed ID: 33714992 [TBL] [Abstract][Full Text] [Related]
12. Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies. Oddis CV Curr Rheumatol Rep; 2005 Apr; 7(2):87-93. PubMed ID: 15760586 [TBL] [Abstract][Full Text] [Related]
13. Physical activity and disablement in the idiopathic inflammatory myopathies. Harris-Love MO Curr Opin Rheumatol; 2003 Nov; 15(6):679-90. PubMed ID: 14569196 [TBL] [Abstract][Full Text] [Related]
14. The assessment and importance of disease activity versus disease damage in patients with inflammatory myopathy. Sultan SM Curr Rheumatol Rep; 2003 Dec; 5(6):445-50. PubMed ID: 14609489 [TBL] [Abstract][Full Text] [Related]
15. "Pregnancy in adult-onset idiopathic inflammatory myopathy": report from a cohort of myositis patients from a single center. Pinal-Fernandez I; Selva-O'Callaghan A; Fernandez-Codina A; Martinez-Gomez X; Rodrigo-Pendas J; Perez-Lopez J; Vilardell-Tarres M Semin Arthritis Rheum; 2014 Oct; 44(2):234-40. PubMed ID: 24906908 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory muscle disease assessment. Lu TY; Ng KP; Isenberg DA Curr Rheumatol Rep; 2008 Aug; 10(4):328-32. PubMed ID: 18662514 [TBL] [Abstract][Full Text] [Related]
17. Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study. Oldroyd A; Dixon W; Chinoy H; Howells K BMC Rheumatol; 2020; 4():47. PubMed ID: 32974608 [TBL] [Abstract][Full Text] [Related]
18. Interrater reliability and aspects of validity of the myositis damage index. Sultan SM; Allen E; Cooper RG; Agarwal S; Kiely P; Oddis CV; Vencovsky J; Lundberg IE; Dastmalchi M; Hanna MG; Isenberg DA Ann Rheum Dis; 2011 Jul; 70(7):1272-6. PubMed ID: 21622773 [TBL] [Abstract][Full Text] [Related]
19. OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies. Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham CO; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H J Rheumatol; 2019 Oct; 46(10):1351-1354. PubMed ID: 30770504 [TBL] [Abstract][Full Text] [Related]
20. Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies. van der Stap DK; Rider LG; Alexanderson H; Huber AM; Gualano B; Gordon P; van der Net J; Mathiesen P; Johnson LG; Ernste FC; Feldman BM; Houghton KM; Singh-Grewal D; Kutzbach AG; Alemo Munters L; Takken T; J Rheumatol; 2016 Jan; 43(1):169-76. PubMed ID: 26568594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]